Axon Enterprise, Inc $AXON Holdings Increased by Cabot Wealth Management Inc.

Cabot Wealth Management Inc. boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 11,781.7% during the 3rd quarter, HoldingsChannel reports. The fund owned 223,139 shares of the biotechnology company’s stock after purchasing an additional 221,261 shares during the period. Axon Enterprise accounts for about 8.7% of Cabot Wealth Management Inc.’s holdings, making the stock its largest position. Cabot Wealth Management Inc.’s holdings in Axon Enterprise were worth $94,281,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. M & L Capital Management Ltd purchased a new stake in Axon Enterprise during the third quarter valued at approximately $30,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Axon Enterprise in the 2nd quarter valued at approximately $31,000. Wealth Enhancement Trust Services Inc. purchased a new position in shares of Axon Enterprise in the 3rd quarter worth approximately $33,000. Putney Financial Group LLC purchased a new position in shares of Axon Enterprise in the 3rd quarter worth approximately $36,000. Finally, Washington Trust Advisors Inc. boosted its holdings in shares of Axon Enterprise by 1,300.0% in the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after purchasing an additional 65 shares during the period. 79.08% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the transaction, the president owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 37,397 shares of company stock valued at $21,234,034. Corporate insiders own 4.20% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on AXON. Royal Bank Of Canada cut their target price on Axon Enterprise from $735.00 to $615.00 and set an “outperform” rating on the stock in a research report on Friday, November 6th. Needham & Company LLC lowered their price target on Axon Enterprise from $750.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, November 6th. Barclays dropped their price objective on shares of Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating for the company in a research note on Monday. Zacks Research lowered shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Finally, Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $390.00 price objective on the stock. in a research report on Friday, November 6th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $612.18.

Recent Axon Enterprise Headlines

Investors following AXON have been watching these headlines:

• Positive Sentiment: Northland maintained a $540 price target despite Axon’s steep decline from its August high, signaling that at least one analyst sees meaningful potential upside. A price target is an estimate, not a guarantee. Axon Is Down 52% From Its August High. Northland Still Sees $540
• Negative Sentiment: Axon’s third-quarter adjusted EPS missed Wall Street expectations, and cautious guidance contributed to a sharp share decline. The company also said federal contract delays shifted $130 million of revenue out of 2026, weighing on near-term expectations. Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
• Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $315.42 on Thursday. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. The firm has a market capitalization of $25.68 billion, a P/E ratio of 101.10, a price-to-earnings-growth ratio of 5.75 and a beta of 1.48. Axon Enterprise, Inc has a 1-year low of $291.45 and a 1-year high of $665.07. The company’s 50-day moving average is $426.24 and its 200 day moving average is $470.65.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.89 by ($0.17). The business had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The firm’s quarterly revenue was up 27.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.17 EPS. Research analysts forecast that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.